Foxboro, MA - June 28, 2006 - Axeda Corporation, a leading provider of enterprise software that enables manufacturers to offer high-value remote services for their products, today announced that it has won a gold M2M Value Chain Award with its customer Respironics (NASDAQ: RESP), a $1B developer, manufacturer, and distributor of innovative sleep and respiratory products. The M2M Value Chain Awards honor the most successful corporate adopters of M2M (Machine-to-Machine) technology and the solution providers that made their success possible.  The companies were recognized for Respironics' Respi-Link™, a next generation remote support solution enabled by Axeda's patented products.

"Our Value Chain award winners were chosen from dozens of entries," said Peggy Smedley, editorial director/president, Specialty Publishing Company / M2M Magazine.  "Respironics and Axeda provide a fantastic example of how product manufacturers and technology providers can collaborate to drive business value and overall customer satisfaction."  

The Respi-Link solution allows Respironics to securely and proactively maintain and service their Esprit® Critical Care ventilators, which drives service cost reductions, increased customer satisfaction, and ultimately improved patient care. Respironics is the first ventilator company in the world to implement this type of program.
 
"We were extremely excited to receive this recognition from M2M Magazine," said Dick Ellis, director, critical care services, Respironics.  "The success of Respi-Link and rapid adoption by our customers is a result of comprehensive planning and working with an experienced technology provider.  We believe we are just scratching the surface of what the solution will ultimately provide to Respironics, our customers, and patients."

Read more about Respi-Link in the Harbor Research Case Study: Medical Device Management - Axeda Platform Enables Ventilators for Remote Upgrades and Diagnostics.  Available for download at www.axeda.com.

About Respironics, Inc.
The Critical Care Group is focused on advancing the science and practice of respiratory care.  Under its Total Ventilation Solutions program, the Group offers a single source to treat, monitor and manage respiratory-impaired patients.   Products include noninvasive and invasive ventilators, monitors, disposable masks and accessories, pulse oximeters and capnography devices.

Respironics is a leading developer, manufacturer and distributor of innovative products and programs that serve the global sleep and respiratory markets. Focusing on emerging market needs, the Company is committed to providing valued solutions to help improve outcomes for patients, clinicians and health care providers. Respironics markets its products in 131 countries and employs over 4,700 associates worldwide. Further information can be found on the Company's Web site: www.respironics.com.

This document contains forward-looking statements, including statements relating to, among other things, developments in the healthcare industry; the success of the Company's marketing, sales, and promotion programs; future sales and acceptance of the Company's products and programs; the timing and success of new product introductions; new product development; anticipated cost savings; FDA and other regulatory requirements and enforcement actions; future results from acquisitions; acquisition integration; growth rates in foreign markets; regulations and other factors affecting operations and sales outside the United States (including potential future effects of the change in sovereignty of Hong Kong); foreign currency fluctuations; customer consolidation and concentration; increasing price competition and other competitive factors in the sale of products; interest rate fluctuations; expiration of intellectual property rights; intellectual property and related litigation; other litigation; future levels of earnings and revenues; and third party reimbursement, all of which are subject to change. Actual results may differ materially from those described in any forward-looking statements. Additional information on potential factors that could affect the Company's financial results are included in the reports filed with the SEC, including the reports on Form 10-K, 10-Q and 8-K.

About Axeda Corporation
Axeda was founded in 2000 with a mission to change the way product manufacturers and service providers deliver services to their customers. With a history of innovation, and over 50 companies using our technology worldwide, Axeda is the leader in the growing market for enterprise software that enables a new generation of high-value remote services.  The company is also the only remote service application provider to receive the prestigious VeriSign® Security Certification. With the most deployments in market, Axeda has a foundation of experience that enables our customers to rapidly achieve their goals. Leading organizations such as Abbott, Cardinal Health, EMC, Diebold, and Quantum are using Axeda solutions today to grow revenue, reduce service and support costs, increase customer satisfaction, and manage risk. For more information, please visit www.axeda.com.  

Axeda is a registered trademark of Axeda Corporation. Axeda DRM, Axeda Device Relationship Management System, Axeda Agents, Axeda Applications, Axeda Policy Manager, Axeda Enterprise, Axeda Access, Axeda Software Management, Axeda Service, Axeda Usage, Firewall-Friendly, Maximum Results, and Maximum Support are trademarks of Axeda Corporation. All other trademarks are either property of Axeda Corporation or property of their respective owners.